Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TPP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PEX1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MTRF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DPY19L1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BCOR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADCK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SSBP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CASD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARL15 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CLIC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OTUD6B-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
UBE2J1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CTDSP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CALU - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BET1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLX1B-SULT1A4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CREBL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MKLN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZBTB44 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPE - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on